A Bristol-based medical technology company fighting the spread of antimicrobial resistance has announced the appointment of its first chief medical officer.

Fluoretiq , which was founded in 2017 and has developed a diagnostic tool called NANOPLEX, named Kasra Saeb-Parsy to the senior role as the company moves a step closer to clinical studies and regulatory approval in the UK and USA...